ZA992899B - Novel compound. - Google Patents

Novel compound.

Info

Publication number
ZA992899B
ZA992899B ZA9902899A ZA992899A ZA992899B ZA 992899 B ZA992899 B ZA 992899B ZA 9902899 A ZA9902899 A ZA 9902899A ZA 992899 A ZA992899 A ZA 992899A ZA 992899 B ZA992899 B ZA 992899B
Authority
ZA
South Africa
Prior art keywords
novel compound
novel
compound
Prior art date
Application number
ZA9902899A
Inventor
Andrew Simon Craig
Alan David Jones
Deirdre O'keeffe
Neal Ward
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of ZA992899B publication Critical patent/ZA992899B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
ZA9902899A 1998-07-02 1999-04-23 Novel compound. ZA992899B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9814316.7A GB9814316D0 (en) 1998-07-02 1998-07-02 Novel compounds

Publications (1)

Publication Number Publication Date
ZA992899B true ZA992899B (en) 2000-03-29

Family

ID=10834803

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA9902899A ZA992899B (en) 1998-07-02 1999-04-23 Novel compound.
ZA200100020A ZA200100020B (en) 1998-07-02 2001-01-02 Salts of paroxetine.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA200100020A ZA200100020B (en) 1998-07-02 2001-01-02 Salts of paroxetine.

Country Status (21)

Country Link
EP (1) EP1091958A1 (en)
JP (1) JP2002519421A (en)
KR (1) KR20010053337A (en)
CN (1) CN1314906A (en)
AP (1) AP2000002017A0 (en)
AU (2) AU4903999A (en)
BG (1) BG105204A (en)
BR (1) BR9911679A (en)
CA (1) CA2336470A1 (en)
CZ (1) CZ20004923A3 (en)
EA (1) EA200100098A1 (en)
GB (1) GB9814316D0 (en)
HU (1) HUP0103712A3 (en)
ID (1) ID27766A (en)
IL (1) IL140385A0 (en)
NO (1) NO20006547L (en)
PL (1) PL345365A1 (en)
SK (1) SK20242000A3 (en)
TR (1) TR200100055T2 (en)
WO (1) WO2000001692A1 (en)
ZA (2) ZA992899B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1622630E (en) 2003-05-07 2012-10-11 Osteologix As Strontium combinations for the prophylaxis/treatment of cartilage and/or bone conditions
PT1534305E (en) 2003-05-07 2007-02-28 Osteologix As Treating cartilage / bone conditions with water-soluble strontium salts
AU2005216596B2 (en) 2004-02-26 2011-03-24 Osteologix A/S Strontium-containing compounds for use in the prevention or treatment of necrotic bone conditions
WO2005108339A2 (en) 2004-05-06 2005-11-17 Osteologix A/S High yield and rapid syntheses methods for producing metallo-organic salts
KR100672184B1 (en) 2004-09-21 2007-01-19 주식회사종근당 Paroxetine cholate or cholic acid derivative salts
US9873667B2 (en) 2006-07-27 2018-01-23 Emisphere Technologies Inc. Arylsulfanyl compounds and compositions for delivering active agents
CN109212055B (en) * 2018-08-19 2021-05-07 丁立平 Gas chromatography-mass spectrometry combined method for determining four trace monohalogenated phenylacetic acids in drinking water
CN109342633B (en) * 2018-11-27 2020-10-02 北京市化工职业病防治院 Method for detecting metabolites of benzene, toluene and xylene in urine
CN111337460B (en) * 2018-12-18 2021-09-17 中国科学院大连化学物理研究所 High-stability Halo-tag probe and synthesis and biological application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8430581D0 (en) * 1984-12-04 1985-01-09 Ferrosan As Treatment
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
CA2206592A1 (en) * 1996-05-30 1997-11-30 Shu-Zhong Wang Method of producing amorphous paroxetine hydrochloride
HU221921B1 (en) * 1996-07-08 2003-02-28 Richter Gedeon Vegyészeti Gyár Rt. N-benzyl-piperidine or tetrahydro-pyridine derivatives and processes for producing them
SK283394B6 (en) * 1997-06-10 2003-07-01 Synthon B. V. 4-phenylpiperidine compounds and its pharmaceutically acceptable salts, process for their preparation, medicament containing them and their use
CA2319652A1 (en) * 1998-02-06 1999-08-12 Michael Urquhart Salts of paroxetine

Also Published As

Publication number Publication date
CA2336470A1 (en) 2000-01-13
NO20006547L (en) 2001-02-12
EA200100098A1 (en) 2001-08-27
AU4903999A (en) 2000-01-24
IL140385A0 (en) 2002-02-10
KR20010053337A (en) 2001-06-25
JP2002519421A (en) 2002-07-02
WO2000001692A1 (en) 2000-01-13
EP1091958A1 (en) 2001-04-18
GB9814316D0 (en) 1998-09-02
SK20242000A3 (en) 2001-07-10
HUP0103712A3 (en) 2002-09-30
TR200100055T2 (en) 2001-07-23
BR9911679A (en) 2002-01-29
CZ20004923A3 (en) 2001-08-15
AP2000002017A0 (en) 2000-12-31
NO20006547D0 (en) 2000-12-21
HUP0103712A2 (en) 2002-05-29
ID27766A (en) 2001-04-26
PL345365A1 (en) 2001-12-17
CN1314906A (en) 2001-09-26
AU2002100370A4 (en) 2002-06-06
BG105204A (en) 2001-11-30
ZA200100020B (en) 2002-03-25

Similar Documents

Publication Publication Date Title
EG24814A (en) Novel compounds.
ZA996185B (en) Sulfanylsilanes.
ZA989767B (en) Novel compounds.
ZA200005136B (en) Dihydropyrimides.
GB0119695D0 (en) Novel compound
ZA991272B (en) Novel thiobenzamides.
GB9805348D0 (en) Compound
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA994085B (en) Compound liquor.
ZA9811758B (en) Novel compounds.
GB9827431D0 (en) Novel compound
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
ZA993123B (en) Trisresorcinyltriazines.
ZA992899B (en) Novel compound.
ZA9811503B (en) Novel compounds.
ZA200006118B (en) Novel composition.
GB9808268D0 (en) Compound
ZA98868B (en) Novel compounds.
ZA200000192B (en) Novel composition.
GB9808896D0 (en) Novel compound
HK1028588A1 (en) Case.
ZA200201714B (en) Novel compound F-15078.
GB9808894D0 (en) Novel compound
ZA99985B (en) New compound.
ZA99942B (en) Novel compounds.